HIV Env-Specific IgG Antibodies Induced by Vaccination of Neonatal Rhesus Macaques Persist and Can Be Augmented by a Late Booster Immunization in Infancy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIV Env-Specific IgG Antibodies Induced by Vaccination of Neonatal Rhesus Macaques Persist and Can Be Augmented by a Late Booster Immunization in Infancy
Authors
Keywords
-
Journal
mSphere
Volume 5, Issue 2, Pages -
Publisher
American Society for Microbiology
Online
2020-04-08
DOI
10.1128/msphere.00162-20
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bridging vaccine-induced HIV-1 neutralizing and effector antibody responses in rabbit and rhesus macaque animal models
- (2019) Justin Pollara et al. JOURNAL OF VIROLOGY
- Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV
- (2019) Sarah Wilmschen et al. Vaccines
- Strategies for a multi-stage neutralizing antibody-based HIV vaccine
- (2018) Raiees Andrabi et al. CURRENT OPINION IN IMMUNOLOGY
- HIV-1 SUBTYPE C INFECTED CHILDREN WITH EXCEPTIONAL NEUTRALIZATION BREADTH EXHIBIT POLYCLONAL RESPONSES TARGETING KNOWN EPITOPES
- (2018) Zanele Ditse et al. JOURNAL OF VIROLOGY
- Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques
- (2018) Bonnie Phillips et al. JOURNAL OF VIROLOGY
- Oral Coadministration of an Intramuscular DNA/Modified Vaccinia Ankara Vaccine for Simian Immunodeficiency Virus Is Associated with Better Control of Infection in Orally Exposed Infant Macaques
- (2018) Alan D. Curtis et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Co-administration of CH31 broadly neutralizing antibody does not affect development of vaccine-induced anti-HIV-1 envelope antibody responses in infant Rhesus macaques
- (2018) Maria Dennis et al. JOURNAL OF VIROLOGY
- Current views on the potential for development of a HIV vaccine
- (2017) Kristen W. Cohen et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine
- (2017) Erin P. McGuire et al. JOURNAL OF VIROLOGY
- HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates
- (2017) Juan García-Arriaza et al. JOURNAL OF VIROLOGY
- Virally vectored vaccine delivery: medical needs, mechanisms, advantages and challenges
- (2017) SWISS MEDICAL WEEKLY
- Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
- (2017) Todd Bradley et al. Nature Communications
- Living and dying to be counted: What we know about the epidemiology of the global adolescent HIV epidemic
- (2017) Amy L. Slogrove et al. Journal of the International AIDS Society
- Progress in HIV vaccine development
- (2017) Denise C. Hsu et al. Human Vaccines & Immunotherapeutics
- Comparison of surface plasmon resonance binding curves for characterization of protein interactions and analysis of screening data
- (2016) Robert Karlsson et al. ANALYTICAL BIOCHEMISTRY
- HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant
- (2016) Cassandra A. Simonich et al. CELL
- Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap
- (2016) Glenda E. Gray et al. Clinical and Vaccine Immunology
- Systemic administration of an HIV-1 broadly neutralizing dimeric IgA yields mucosal secretory IgA and virus neutralization
- (2016) G G Fouda et al. Mucosal Immunology
- Maternal HIV-1 envelope–specific antibody responses and reduced risk of perinatal transmission
- (2015) Sallie R. Permar et al. JOURNAL OF CLINICAL INVESTIGATION
- Ending the Global HIV/AIDS Pandemic: The Critical Role of an HIV Vaccine
- (2014) A. S. Fauci et al. CLINICAL INFECTIOUS DISEASES
- Infant HIV Type 1 gp120 Vaccination Elicits Robust and Durable Anti-V1V2 Immunoglobulin G Responses and Only Rare Envelope-Specific Immunoglobulin A Responses
- (2014) Genevieve G. Fouda et al. JOURNAL OF INFECTIOUS DISEASES
- HIV-1 neutralizing antibodies: understanding nature's pathways
- (2013) John R. Mascola et al. IMMUNOLOGICAL REVIEWS
- Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen
- (2013) Heather E. Lynch et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Extended Evaluation of the Virologic, Immunologic, and Clinical Course of Volunteers Who Acquired HIV-1 Infection in a Phase III Vaccine Trial of ALVAC-HIV and AIDSVAX B/E
- (2012) Supachai Rerks-Ngarm et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
- (2012) M. Bonsignori et al. JOURNAL OF VIROLOGY
- Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144
- (2012) Merlin L Robb et al. LANCET INFECTIOUS DISEASES
- High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses
- (2011) Justin Pollara et al. CYTOMETRY PART A
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started